# Ascentage Pharma Group International: Form 6-K, filed Sep 29, 2026

- Company: [Ascentage Pharma Group International](/companies/aapg.md) (CIK 2023311)
- Form: 6-K
- Filed: 2026-09-29
- Accepted by EDGAR: Sep 28, 2026, 18:14 ET
- Period: 2026-09-28
- Accession: 0001213900-26-104196
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2023311/000121390026104196/ea0306919-6k_ascentage.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2023311/000121390026104196/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2023311/000121390026104196/ea0306919-6k_ascentage.htm

Filed Sep 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-104196. Last ingested by Listed: Nov 5, 2026, 12:38 ET. No prices; not investment advice.